[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 806
Citations 0
Comment & Response
April 14, 2015

Aspirin for Prevention of Cardiovascular Events in Older Japanese Patients

Author Affiliations
  • 1Western University, London, Ontario, Canada
JAMA. 2015;313(14):1473. doi:10.1001/jama.2015.2574

To the Editor The study by Dr Ikeda and colleagues1 on low-dose aspirin for primary prevention in patients who are at risk of cardiovascular events was stopped early for futility with regard to the primary outcome, which was “a composite of death from cardiovascular causes (myocardial infarction, stroke, and other cardiovascular causes), nonfatal stroke (ischemic or hemorrhagic, including undefined cerebrovascular events), and nonfatal myocardial infarction.”